SEC Form 4 · accession 0001104659-18-019370
Mersana Therapeutics, Inc. · MRSN
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Willard H Dere
Director
Period of report
Mar 19, 2018
Accepted (ET)
Mar 21, 2018 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001442836
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (right to buy)F1 | $17.38 | Mar 19, 2018 | A | 20,000 | A | — | Mar 19, 2021 | Common Stock | 20,000 | 20,000 | D |
Explanation of responses
- F1The option becomes exercisable in equal quarterly installments over three years from the date of the grant.